In this article, we will discuss Durvalumab (Dosage Duration-1). So, let’s get started.
Unresectable stage III NSCLC
- Until disease progression, unacceptable toxicity, or a maximum of 12 months
Categories
Durvalumab (Dosage Duration-1)
In this article we will discuss Durvalumab (Dosage Duration-1)